Diagnostic performance of whole-body MRI for the detection of persistent or relapsing disease in multiple myeloma after stem cell transplantation
- 29 April 2012
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 22 (9) , 2007-2012
Abstract
To compare the diagnostic performance of whole-body MRI (WBMRI) with haematological parameters for detecting persistent or relapsing disease in patients with multiple myeloma after stem cell transplantation.Keywords
This publication has 25 references indexed in Scilit:
- Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1Blood, 2011
- Multiple MyelomaNew England Journal of Medicine, 2011
- International Myeloma Working Group Consensus Statement Regarding the Current Status of Allogeneic Stem-Cell Transplantation for Multiple MyelomaJournal of Clinical Oncology, 2010
- NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, Acute Leukemias, and Myelodysplastic SyndromesTransplantation and Cellular Therapy, 2010
- Multiple Myeloma Treatment Response Assessment with Whole-Body Dynamic Contrast-enhanced MR ImagingRadiology, 2010
- Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Importance of Whole-Body versus Spinal MR ImagingRadiology, 2009
- Multiple myeloma: ESMO Clinical Recommendations for diagnosis, treatment and follow-upAnnals of Oncology, 2009
- The role of anatomic and functional staging in myeloma: Description of Durie/Salmon plus staging systemEuropean Journal of Cancer, 2006
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Multiple myelomaThe Lancet, 2004